Health Economics and Market Access for Orphan Drugs

Orphan drug development comes with high costs that pose challenges to market access. Health economics plays a pivotal role in assessing the value and cost-effectiveness of treatments. New models of pricing, reimbursement strategies, and health technology assessments (HTAs) help balance affordability and company sustainability. Patient assistance programs and partnerships with non-profits are essential for equitable access to life-saving treatments. Addressing economic and market challenges ensures that orphan drugs can benefit those who need them most.

 

    Health Economics and Market Access for Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in